Sponsors: []Modifications: ,,the followingindividuals are not liable for any civil damages for acts or omissions made as a result ofadministering an opiate antagonist when the individualthe:(A)  an overdose outreach provider; or(B)  a person other than a health care facility or health care provider.isimmuneis immunefor an individual described in Subsection (2)(a)(i),thethe opiate antagonistdescribed in Subsection (2)(a)(i) or (ii)Full text:



1     OPIATE OVERDOSE RESPONSE ACT AMENDMENTS2     2017 GENERAL SESSION3     STATE OF UTAH4     Chief Sponsor:  Carol Spackman Moss5     Senate Sponsor:  ____________6      7     LONG TITLE8     General Description:9          This bill clarifies civil liability in the Opiate Overdose Response Act.10     Highlighted Provisions:11          This bill:12                clarifies the persons who are not civilly liable when administering an opiate13     antagonist under certain circumstances; and14                makes technical changes.15     Money Appropriated in this Bill:16          None17     Other Special Clauses:18          None19     Utah Code Sections Affected:20     AMENDS:21          26-55-104, as last amended by Laws of Utah 2016, Chapters 202, 207, 208 and last22     amended by Coordination Clause, Laws of Utah 2016, Chapter 20223      24     Be it enacted by the Legislature of the state of Utah:25          Section 1.  Section 26-55-104 is amended to read:26          26-55-104. Prescribing, dispensing, and administering an opiate antagonist --27     Immunity from liability.28          (1) (a) (i)  For purposes of Subsection (1)(a)(ii), "a person other than a health care29     facility or health care provider" includes  the following, regardless of whether the person has30     received funds from the department through the Opiate Overdose Outreach Pilot Program31     created in Section 26-55-107: 32          (A)  a person described in Subsections 26-55-107(1)(a)(i)(A) through (1)(a)(i)(F); or33          (B)  an organization, defined by department rule made under Subsection34     26-55-107(7)(e), that is in a position to assist an individual who is at increased risk of35     experiencing an opiate-related drug overdose event.36          (ii)  Except as provided in Subsection (1)(b), [a person, including an overdose outreach37     provider, but not including a health care facility or health care provider, that] the following38     individuals are not liable for any civil damages for acts or omissions made as a result of39     administering an opiate antagonist when the individual acts in good faith to administer [an] the40     opiate antagonist to an individual whom the person believes to be experiencing an41     opiate-related drug overdose event [is not liable for any civil damages for acts or omissions42     made as a result of administering the opiate antagonist.]:43          (A)  an overdose outreach provider; or44          (B)  a person other than a health care facility or health care provider.45          (b)  A health care provider:46          (i)  [does] is not [have immunity] immune from liability under Subsection (1)(a) when47     the health care provider is acting within the scope of the health care provider's responsibilities48     or duty of care; and49          (ii)  [does have immunity] is immune from liability under Subsection (1)(a) if the health50     care provider is under no legal duty to respond and otherwise complies with Subsection (1)(a).51          (2)  Notwithstanding Sections 58-1-501, 58-17b-501, and 58-17b-502, a health care52     provider who is licensed to prescribe an opiate antagonist may prescribe, including by a53     standing prescription drug order issued in accordance with Subsection 26-55-105(2), or54     dispense an opiate antagonist:55          (a) (i)  to an individual who is at increased risk of experiencing an opiate-related drug56     overdose event;57          (ii)  for an individual described in Subsection (2)(a)(i), to a family member [of], friend58     [of], or other person, including a person described in Subsections 26-55-107(1)(a)(i)(A)59     through (1)(a)(i)(F), that is in a position to assist [an] the individual [who is at increased risk of60     experiencing an opiate-related drug overdose event]; or61          (iii)  to an overdose outreach provider for:62          (A)  furnishing the opiate antagonist to an individual [who is at increased risk of63     experiencing an opiate-related drug overdose event, or to a family member of, friend of, or64     other individual who is in a position to assist an individual who is at increased risk of65     experiencing an opiate-related drug overdose event] described in Subsection (2)(a)(i) or (ii), as66     provided in Section 26-55-106; or67          (B)  administering to an individual experiencing an opiate-related drug overdose event;68          (b)  without a prescriber-patient relationship; and69          (c)  without liability for any civil damages for acts or omissions made as a result of70     prescribing or dispensing the opiate antagonist in good faith.71          (3)  A health care provider who dispenses an opiate antagonist to an individual or an72     overdose outreach provider under Subsection (2)(a) shall provide education to the individual or73     overdose provider that includes written instruction on how to:74          (a)  recognize an opiate-related drug overdose event; and75          (b)  respond appropriately to an opiate-related drug overdose event, including how to:76          (i)  administer an opiate antagonist; and77          (ii)  ensure that an individual to whom an opiate antagonist has been administered78     receives, as soon as possible, additional medical care and a medical evaluation.Legislative Review NoteOffice of Legislative Research and General Counsel

